Unlike traditional glass carpules, which are costly and time-consuming to produce, the BFS carpules are lightweight, durable, and significantly more economical.
Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback